Infect Dis Clin North Am. 1993;7:9 19. 91. Pallasch TJ, Wahl MJ. Focal infection: new age or ancient history? Endodontic Topics. 2003;4:32 45. 92. Idsoe O, Guthe T, Willcox RR, de Weck AL. Nature and extent of penicillin side-reactions, with particular reference to fatalities from ana- phylactic shock. Bull World Health Organ. 1968;38:159 188. 93. Ahlstedt S. Penicillin allergy: can the incidence be reduced? Allergy. 1984;39:151 164. 94. Agha Z, Lofgren RP, VanRuiswyk JV. Is antibiotic prophylaxis for bac- terial endocarditis cost-effective? Med Decis Making. 2005;25:308 320. 95. Kelkar PS, Li JT. Cephalosporin allergy. N Engl J Med. 2001;345: 804 809. 96. Guay DR, Patterson DR, Seipman N, Craft JC. Overview of the toler- ability profile of clarithromycin in preclinical and clinical trials. Drug Saf. 1993;8:350 364. 97. Mazur N, Greenberger PA, Regalado J. Clindamycin hypersensitivity appears to be rare. Ann Allergy Asthma Immunol. 1999;82:443 445. 98. Bombassaro AM, Wetmore SJ, John MA. Clostridium difficile colitis following antibiotic prophylaxis for dental procedures. J Can Dent Assoc. 2001;67:20 22. 99. Tleyjeh IM, Steckelberg JM, Murad HS, Anavekar NS, Ghomrawi HM, Mirzoyev Z, Moustafa SE, Hoskin TL, Mandrekar JN, Wilson WR, Baddour LM. Temporal trends in infective endocarditis: a population-based study in Olmsted County, Minnesota. JAMA. 2005;293:3022 3028. 100. Griffin MR, Wilson WR, Edwards WD, O Fallon WM, Kurland LT. Infective endocarditis: Olmsted County, Minnesota, 1950 through 1981. JAMA. 1985;254:1199 1202. 101. Durack DT, Petersdorf RG. Changes in the epidemiology of endocarditis. Paper presented at: Infective Endocarditis: An American Heart Association Symposium; held May 14 15, 1976. In: AHA Monograph #52, 1977. 102. Delahaye F, Goulet V, Lacassin F, et al. Characteristics of infective endo- carditis in France in 1991: a 1-year survey. Eur Heart J. 1995;16:394 401. 103. 